Targeted Protein Degradation: Principles and Applications of the Proteasome

被引:18
作者
Kim, Yosup [1 ]
Kim, Eun-Kyung [1 ]
Chey, Yoona [1 ]
Song, Min-Jeong [1 ]
Jang, Ho Hee [1 ,2 ,3 ]
机构
[1] Gachon Univ, Coll Med, Dept Biochem, Incheon 21999, South Korea
[2] Gachon Univ, Gachon Adv Inst Hlth Sci & Technol GAIHST, Dept Hlth Sci & Technol, Incheon 21999, South Korea
[3] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Incheon 21999, South Korea
基金
新加坡国家研究基金会;
关键词
proteasome; targeted protein degradation; E3 ubiquitin ligase; ubiquitin; PROTAC; UBIQUITIN-INDEPENDENT DEGRADATION; DEPENDENT PROTEOLYTIC SYSTEM; OXIDIZED PROTEINS; DOWN-REGULATION; 26S PROTEASOME; ACTIVATOR PA28; E3; LIGASE; ORNITHINE-DECARBOXYLASE; 20S PROTEASOME; CDNA CLONING;
D O I
10.3390/cells12141846
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The proteasome is a multi-catalytic protease complex that is involved in protein quality control via three proteolytic activities (i.e., caspase-, trypsin-, and chymotrypsin-like activities). Most cellular proteins are selectively degraded by the proteasome via ubiquitination. Moreover, the ubiquitin-proteasome system is a critical process for maintaining protein homeostasis. Here, we briefly summarize the structure of the proteasome, its regulatory mechanisms, proteins that regulate proteasome activity, and alterations to proteasome activity found in diverse diseases, chemoresistant cells, and cancer stem cells. Finally, we describe potential therapeutic modalities that use the ubiquitin-proteasome system.
引用
收藏
页数:25
相关论文
共 216 条
[1]   PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex [J].
Abbas, Tarek ;
Sivaprasad, Uma ;
Terai, Kenta ;
Amador, Virginia ;
Pagano, Michele ;
Dutta, Anindya .
GENES & DEVELOPMENT, 2008, 22 (18) :2496-2506
[2]   Functional Differences between Proteasome Subtypes [J].
Abi Habib, Joanna ;
Lesenfants, Julie ;
Vigneron, Nathalie ;
van den Eynde, Benoit J. .
CELLS, 2022, 11 (03)
[3]   Identification of Pancreatic Cancer Stem Cells and Selective Toxicity of Chemotherapeutic Agents [J].
Adikrisna, Rama ;
Tanaka, Shinji ;
Muramatsu, Shunsuke ;
Aihara, Arihiro ;
Ban, Daisuke ;
Ochiai, Takanori ;
Irie, Takumi ;
Kudo, Atsushi ;
Nakamura, Noriaki ;
Yamaoka, Shoji ;
Arii, Shigeki .
GASTROENTEROLOGY, 2012, 143 (01) :234-U448
[4]   In vivo characterization of the proteasome regulator PA28 [J].
Ahn, K ;
Erlander, M ;
Leturcq, D ;
Peterson, PA ;
Fruh, K ;
Yang, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) :18237-18242
[5]   CDNA CLONING AND INTERFERON-GAMMA DOWN-REGULATION OF PROTEASOMAL SUBUNIT-X AND SUBUNIT-Y [J].
AKIYAMA, KY ;
YOKOTA, KY ;
KAGAWA, S ;
SHIMBARA, N ;
TAMURA, T ;
AKIOKA, H ;
NOTHWANG, HG ;
NODA, C ;
TANAKA, K ;
ICHIHARA, A .
SCIENCE, 1994, 265 (5176) :1231-1234
[6]   Control of AMPK-related kinases by USP9X and atypical Lys29/Lys33-inked polyubiquitin chains [J].
Al-Hakim, Abdallah K. ;
Zagorska, Anna ;
Chapman, Louise ;
Deak, Maria ;
Peggie, Mark ;
Alessi, Dario R. .
BIOCHEMICAL JOURNAL, 2008, 411 :249-260
[7]   Mechanism of direct degradation of IκBα by 20S proteasome [J].
Alvarez-Castelao, B ;
Castaño, JG .
FEBS LETTERS, 2005, 579 (21) :4797-4802
[8]   Mechanism and function of deubiquitinating enzymes [J].
Amerik, AY ;
Hochstrasser, M .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2004, 1695 (1-3) :189-207
[9]   The Role of E3, E4 Ubiquitin Ligase (UBE4B) in Human Pathologies [J].
Antoniou, Nikolaos ;
Lagopati, Nefeli ;
Balourdas, Dimitrios Ilias ;
Nikolaou, Michail ;
Papalampros, Alexandros ;
Vasileiou, Panagiotis V. S. ;
Myrianthopoulos, Vassilios ;
Kotsinas, Athanassios ;
Shiloh, Yosef ;
Liontos, Michalis ;
Gorgoulis, Vassilis G. .
CANCERS, 2020, 12 (01)
[10]   Reactive oxygen species: Metabolism, oxidative stress, and signal transduction [J].
Apel, K ;
Hirt, H .
ANNUAL REVIEW OF PLANT BIOLOGY, 2004, 55 :373-399